Molecule may predict chemo effectiveness

Published: Sept. 5, 2007 at 12:12 PM

CINCINNATI, Sept. 5 (UPI) -- U.S. medical scientists have discovered a molecular pathway might help physicians predict which lung cancer patients will benefit from chemotherapy.

University of Cincinnati researchers said the molecule -- known as the retinoblastoma, or RB, tumor suppressor -- regulates cell proliferation in the body. Research has shown the RB pathway is either entirely inactive or altered in most human cancers.

Dr. Michael Reed and colleagues at the University of Cincinnati found "turning off" the RB pathway in lung cancer cells resulted in an altered response to chemotherapy agents and more cancer cell death.

"Dissecting the RB pathway will help us better understand how chemotherapy works and predict which patients might benefit from therapy and which ones won’t," said Reed.

The findings are reported in the journal Cancer Research.

© 2007 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Car brake particles harm lung cells (2 min)
LHC generates first proton beam collision (10 min)
Markets romp Monday (18 min)
Thanksgiving turkey filled with booze (31 min)
Thanksgiving can be challenge for seniors
Michigan lawmaker seeks official tartan
Economist: China should give yuan a boost
fark
Grandparents are cool because they let you do things mom and dad won't. Like, say, hanging onto...
Today's most incoherent actual headline: "Trooper fired after hat fib wants back in"
Photoshop this held horse
How the Resale Subculture drives Black Friday, why Cyber Monday is a hoax, and some of Fark's favorite...
Under the new administration, sex slavery for the mentally handicapped is no longer on the list...
Van carrying cheerleaders flips, twirls, spins and splits on the interstate